Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.58
-0.28 (-3.16%)
Nov 20, 2024, 4:00 PM EST - Market closed
Actuate Therapeutics Employees
Actuate Therapeutics had 5 employees as of December 31, 2023.
Employees
5
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,690,279
Market Cap
167.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
2seventy bio | 274 |
Nkarta | 150 |
BrainsWay | 134 |
Senseonics Holdings | 132 |
Heron Therapeutics | 126 |
Stereotaxis | 122 |
Verastem | 73 |
ACTU News
- 22 days ago - Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development - GlobeNewsWire
- 2 months ago - Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma - GlobeNewsWire
- 2 months ago - Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - U.S. IPO Weekly Recap: WeRide Reschedules While 6 New Filers Join The Pipeline - Seeking Alpha
- 3 months ago - Actuate Therapeutics Announces Closing of Initial Public Offering - GlobeNewsWire
- 3 months ago - Actuate Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 3 months ago - U.S. IPO Weekly Recap: August Kicks Off With One Small Pricing - Seeking Alpha
- 4 months ago - U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week - Seeking Alpha